Drug Shortage Report for AURO-OLMESARTAN HCTZ

Last updated on 2024-04-25 History
Report ID 106080
Drug Identification Number 02476487
Brand name AURO-OLMESARTAN HCTZ
Common or Proper name Hydrochlorothiazide; Olmesartan Medoxil
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL
Strength(s) 12.5MG 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-11-15
Estimated end date 2024-05-31
Actual end date
Shortage status Actual shortage
Updated date 2024-04-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v31 2024-04-25 French Compare
v30 2024-04-25 English Compare
v29 2024-04-25 French Compare
v28 2024-04-25 English Compare
v27 2024-04-25 French Compare
v26 2024-04-25 English Compare
v25 2024-03-27 French Compare
v24 2024-03-27 English Compare
v23 2023-12-28 French Compare
v22 2023-12-28 English Compare
v21 2023-11-16 English Compare
v20 2023-11-15 French Compare
v19 2023-11-15 English Compare
v18 2023-11-15 French Compare
v17 2023-11-15 English Compare
v16 2023-11-15 French Compare
v15 2023-11-15 English Compare
v14 2021-03-25 French Compare
v13 2021-03-25 English Compare
v12 2021-02-12 French Compare

Showing 1 to 20 of 31